This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatuur
Birks J, Grimley Evans J, Iakovidou V, et al. Rivastigmine for Alzheimer’s disease. Cochrane Database Syst Rev. 2008(3):CD001191.
Birks J, Harvey RJ. Donepezil for dementia due to Alzheimer’s disease. Cochrane Database Syst Rev. 2006(1):CD001190.
EBRO. Richtlijn Diagnostiek en medicamenteuze behandeling van dementie. Utrecht: Evidence-Based Richtlijn Ontwikkeling (EBRO). Van Zuiden Communications; 2005.
McKeith I, Del Ser T, Spano P, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet. 2000;356(9247):2031-6.
Reisberg B, Doody R, Stöffler A, et al. Memantine in moderate-to-severe Alzheimer’s Disease. N Engl J Med. 2003;348:1333-41.
Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. The Alzheimer’s Disease Cooperative Study. N Engl J Med. 1997;336:1216-22.
Schenk D, Barber R, Dunn W. Immunisation with beta-amyloid attenuates Alzheimer Disease like pathology in the PDAPP mouse. Nature. 1999;400:173-7.
Sink KM, Holden KF, Yaffe K. Pharmacological treatmentimplicaations of neuropsychiatric symptoms of dementia. JAMA. 2005;293:596-608.
Tariot PN, Farlow MR, Grossberg GT, et al. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA. 2004;291(3):317-24.
Trinh N, Hoblyn J, Mohanty S, et al. Efficacy of cholinesterase-inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer’s disease: a meta-analysis. JAMA. 2003;289:210-6.
Verhey FRJ, Heeren TJ, Scheltens P, et al. Cholinesterase remmers bij de ziekte van Alzheimer: voorlopige aanbevelingen voor de toepassing in de praktijk. Ned Tijdschr Geneeskd. 1998;142:2091-6.
Visser PJ, Scheltens P, Pelgrim E, et al. Medial Temporal Lobe Atrophy and APOE Genotype Do Not Predict Cognitive Improvement upon Treatment with Rivastigmine in Alzheimer’s Disease Patients. Dement Geriatr Cogn Disord. 2004;19(2-3):126-33.
Winblad B, Engedal K, Soininen H, et al. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology. 2001;57(3):489-95.
Winblad B, Poritis N. memantine in severe dementia: results of the M-BEST study (benefit and efficacy in severely demented patients during treatment with memantine). Int J Geriat Psychiatry. 1999;14:135-46.
Aanbevolen literatuur
Auchus AP, Brashear HR, Salloway S, et al. Galantamine treatment of vascular dementia. Neurology. 2007;69:448-58.
Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352:1347-51.
Hogan DB, Bailey P, Black S, et al. Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia. CMAJ. 2008;179:1019-26.
Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol. 2007;6:782-92.
Laurin D, Verreault R, Lindsay J, et al. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol. 2001;58:498-504.
McGuinness B, Craig D, Bullock R, et al. Statins for the prevention of dementia. Cochrane Database Syst Rev. 2008(4):CD003160.
Patterson C, Feightner JW, Garcia A, et al. Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. CMAJ. 2008;178:548-56.
Raina P, Santaguida P, Ismaila A, et al. Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline. Ann Intern Med. 2008;148: 379-97.
Shors TJ. Saving new brain cells. Scientific American. 2009;200(3):41-8
Sofi F, Cesari F, Abbate R, et al. Adherence to Mediterranean diet and health status: meta-analysis. BMJ. 2008;337:a1344.
Willis SL, Tennstedt SL, Marsiske M, et al. Long-term effects of cognitive training on everyday functional outcomes in older adults. JAMA. 2006;296:2805-14.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Bohn Stafleu van Loghum, onderdeel van Springer Uitgeverij
About this chapter
Cite this chapter
Slaets, J., Verhey, F. (2009). 11 Behandeling en preventie van cognitieve stoornissen. In: Jonker, C., Slaets, J., Verhey, F. (eds) Handboek dementie. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-8061-9_11
Download citation
DOI: https://doi.org/10.1007/978-90-313-8061-9_11
Publisher Name: Bohn Stafleu van Loghum, Houten
Print ISBN: 978-90-313-6228-8
Online ISBN: 978-90-313-8061-9
eBook Packages: Dutch language eBook collection